Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
1171
mi
from
Long Beach, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Los Angeles NICHD CRS
1169
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Los Angeles NICHD CRS
1169
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
1177
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of California, UC San Diego CRS
1142
mi
from
San Diego, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of California, UC San Diego CRS
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of California San Francisco NICHD CRS
1341
mi
from
San Francisco, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of California San Francisco NICHD CRS
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Harbor UCLA Medical Center NICHD CRS
1176
mi
from
Torrance, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Harbor UCLA Medical Center NICHD CRS
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Colorado Denver NICHD CRS
402
mi
from
Aurora, CO
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Colorado Denver NICHD CRS
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
1127
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
1127
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Howard Univ. Washington DC NICHD CRS
1127
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Howard Univ. Washington DC NICHD CRS
1127
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
1309
mi
from
Fort Lauderdale, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
1309
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Florida Jacksonville NICHD CRS
1053
mi
from
Jacksonville, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Florida Jacksonville NICHD CRS
1053
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
1320
mi
from
Miami, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
USF - Tampa NICHD CRS
1114
mi
from
Tampa, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
USF - Tampa NICHD CRS
1114
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
608
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rush Univ. Cook County Hosp. Chicago NICHD CRS
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
611
mi
from
Chicago, IL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Tulane Univ. New Orleans NICHD CRS
697
mi
from
New Orleans, LA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Tulane Univ. New Orleans NICHD CRS
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Maryland Baltimore NICHD CRS
1148
mi
from
Baltimore, MD
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Maryland Baltimore NICHD CRS
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hosp. of Boston NICHD CRS
1444
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hosp. of Boston NICHD CRS
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
1444
mi
from
Boston, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Boston Medical Center Ped. HIV Program NICHD CRS
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
1408
mi
from
Worcester, MA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
WNE Maternal Pediatric Adolescent AIDS CRS
1408
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Michigan NICHD CRS
841
mi
from
Detroit, MI
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Michigan NICHD CRS
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Rutgers - New Jersey Medical School CRS
1276
mi
from
Newark, NJ
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Rutgers - New Jersey Medical School CRS
1276
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Bronx-Lebanon CRS
1292
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Bronx-Lebanon CRS
1292
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
1295
mi
from
Bronx, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Jacobi Med. Ctr. Bronx NICHD CRS
1295
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Nyu Ny Nichd Crs
1288
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Nyu Ny Nichd Crs
1288
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Metropolitan Hosp. NICHD CRS
1290
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Metropolitan Hosp. NICHD CRS
1290
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Columbia IMPAACT CRS
1290
mi
from
New York, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Columbia IMPAACT CRS
1290
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
1121
mi
from
Rochester, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Strong Memorial Hospital Rochester NY NICHD CRS
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
SUNY Stony Brook NICHD CRS
1358
mi
from
Stony Brook, NY
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
SUNY Stony Brook NICHD CRS
1358
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
DUMC Ped. CRS
1052
mi
from
Durham, NC
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
DUMC Ped. CRS
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
1223
mi
from
Philadelphia, PA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
The Children's Hosp. of Philadelphia IMPAACT CRS
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
St. Jude Children's Research Hospital CRS
468
mi
from
Memphis, TN
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
St. Jude Children's Research Hospital CRS
468
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Texas Children's Hosp. CRS
572
mi
from
Houston, TX
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Texas Children's Hosp. CRS
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Seattle Children's Research Institute CRS
1410
mi
from
Seattle, WA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Seattle Children's Research Institute CRS
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
2331
mi
from
San Juan,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of Puerto Rico Pediatric HIV/AIDS Research Program CRS
2331
mi
from
San Juan,
Click here to add this to my saved trials
Network Supported Engagement In HIV Care
Network Supported Engagement In HIV Care
Status: Enrolling
Updated:  1/13/2016
University of Chicago Medical Center
609
mi
from
Chicago, IL
Network Supported Engagement In HIV Care
Network Supported Engagement In HIV Care
Status: Enrolling
Updated: 1/13/2016
University of Chicago Medical Center
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
University of Oklahoma
158
mi
from
Oklahoma City, OK
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
University of Oklahoma
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated:  1/13/2016
St. Petersburg State University
1207
mi
from
St. Peterburg,
Expansion to Interdisciplinary HIV Prevention in Women
Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women
Status: Enrolling
Updated: 1/13/2016
St. Petersburg State University
1207
mi
from
St. Peterburg,
Click here to add this to my saved trials
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Status: Enrolling
Updated:  1/15/2016
LA County Jail
1168
mi
from
Los Angeles, CA
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Status: Enrolling
Updated: 1/15/2016
LA County Jail
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Southwest Center for HIV/AIDS
851
mi
from
Phoenix, AZ
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Southwest Center for HIV/AIDS
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Health for Life Clinic, PLLC
368
mi
from
Little Rock, AR
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Health for Life Clinic, PLLC
368
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
AIDS Healthcare Foundation-Research Center
1175
mi
from
Beverly HIlls, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
AIDS Healthcare Foundation-Research Center
1175
mi
from
Beverly HIlls, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Living Hope Foundation
1171
mi
from
Long Beach, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Living Hope Foundation
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Peter J. Ruane, MD, Inc.
1173
mi
from
Los Angeles, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Peter J. Ruane, MD, Inc.
1173
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Orange Coast Medical Group
1161
mi
from
Newport Beach, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Orange Coast Medical Group
1161
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
David J. Shamblaw, MD Inc.
1142
mi
from
San Diego, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
David J. Shamblaw, MD Inc.
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Metropolis Medical
1340
mi
from
San Francisco, CA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Metropolis Medical
1340
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Denver Infectious Disease Consultants, PLLC
406
mi
from
Denver, CO
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Denver Infectious Disease Consultants, PLLC
406
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Dupont Circle Physician's Group
1127
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Dupont Circle Physician's Group
1127
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Whitman Walker Clinic
1127
mi
from
Washington,
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Whitman Walker Clinic
1127
mi
from
Washington,
Click here to add this to my saved trials